Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Dig Dis Sci ; 63(1): 36-45, 2018 01.
Article in English | MEDLINE | ID: mdl-29147880

ABSTRACT

BACKGROUND: Prior studies have shown poor compliance with quality measures for IBD at academic and private practices. We sought to provide focused interventions to improve compliance and documentation with the IBD measures. METHODS: Two centers, academic practice (AP) and private practice (PP), initially reviewed their compliance with eight established IBD quality measures in consecutive charts. A multi-faceted intervention was developed to improve awareness and documentation of these measures. The initial data and the quality measures were reviewed at a group meeting. Following this, a handout summarizing the measures was placed in each exam room. The AP added a new screen to the EHR that summarized the relevant IBD history, while the PP added a new template that was filled out and imported into the charts. Three months after this intervention, charts were reviewed for compliance with the measures. RESULTS: The intervention cohort consisted of 768 patients (AP = 569/PP = 199) compared to the initial cohort of 566 patients (AP = 367/PP = 199). Improvement was seen throughout all measures compared to the initial cohort. The AP reported compliance with all relevant measures in 21% and the PP in 60% compared to 7 and 10% in the initial cohort. PP had ≥ 75% compliance with every measure, of which only assessment for bone loss and pneumococcal vaccination was under 80%. In contrast, the AP compliance ranged from 35 to 100% with assessment for bone loss, influenza, and pneumococcal vaccination scoring lowest. CONCLUSION: Our study demonstrates that focused low-cost interventions can significantly improve compliance with IBD quality measures in different practice settings.


Subject(s)
Documentation/standards , Education, Medical , Inflammatory Bowel Diseases/diagnosis , Physicians , Academic Medical Centers , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Health Services Research , Humans , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/pathology , Male , Medical Records , Middle Aged , Private Practice , Young Adult
2.
J Med Syst ; 40(9): 196, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27447470

ABSTRACT

Significant attention has been directed towards developing the medical home and improving the patient experience. The medical home is targeted towards optimizing the quality of patient care while also reducing overall costs. An extension of the medical home is the concept of a medical neighborhood. The medical neighborhood utilizes the success of the medical home and incorporates it into the coordination of care between primary care physician and specialists. In order to create an ideal system, though, the framework for making referrals, ordering tests prior to referrals, documentation and communication of recommendations must be addressed a priori. In this perspective we discuss the necessary steps to implement a medical neighborhood for patients with chronic medical conditions and the use of medical technology to facilitate this process.


Subject(s)
Patient-Centered Care , Program Development/methods , Biomedical Technology , Chronic Disease/therapy , Interdisciplinary Communication , Interprofessional Relations , Primary Health Care/standards , Quality Improvement , Referral and Consultation , Specialization
3.
J Altern Complement Med ; 19(8): 729-31, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23379829

ABSTRACT

OBJECTIVES: This study reports on the safety of the complementary and alternative medicine (CAM) practice of cupping in a patient undergoing concomitant therapy with bevacizumab for advanced non-small-cell lung cancer (NSCLC), and raises awareness of the need for improved communication between CAM practitioners and oncologists during the care of patients with cancer. The practice of cupping generates local hyperemia, disrupts superficial vasculature in the dermis, and leads to cutaneous lesions including circular erythema, edema, and subsequently ecchymosis. There are no data on the safety of cupping in patients being treated with bevacizumab. DESIGN: This is a single-institution case report. SETTINGS/LOCATION: The setting for this study was a tertiary-care academic medical center. CONCLUSIONS: A patient with advanced NSCLC received four cycles of carboplatin AUC 6, paclitaxel 200 mg/m(2), and bevacizumab 15 mg/kg, and was continued on every-3-week maintenance bevacizumab 15 mg/kg. The patient underwent glass dry cupping during cycle six of maintenance bevacizumab treatment without overt cutaneous adverse events or bleeding. The patient did not realize he should have communicated his cupping plans or recent bevacizumab treatment with his providers.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Medicine, Chinese Traditional/methods , Bevacizumab , Humans , Male , Middle Aged , Skin Physiological Phenomena
SELECTION OF CITATIONS
SEARCH DETAIL
...